Evidence map›Paper›PMID 33850728›Full record

ArticleUrology case reports2021

Is corona virus infection a risk factor for hematuria in secondary bladder amyloidosis? The first case report.

Anahita Ansari Djafari, Katayoun Hasanzadeh, Homa Masrour, Mahsa Ahadi, Majid Dargahi, Amirhossein Rahavian

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Urology case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. SARS-CoV-2 Effects on the Male Genitourinary System.American journal of clinical and experimental urology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Anahita Ansari DjafariUrology, Department of Urology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Katayoun HasanzadehInternal Medicine Ward, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Homa MasrourInternal Medicine Ward, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mahsa AhadiDepartment of Pathology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Majid DargahiUrology, Department of Urology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Amirhossein RahavianAndrology Research Center, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Shahid Beheshti University of Medical Sciences · IRShahid Sadoughi University of Medical Sciences and Health Services · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Urogenital amyloidosis is a rare disease that involved every site of the urogenital system. Involvement of bladder developed with gross hematuria, and any intrinsic or extrinsic stresses exacerbate hematuria. We reported a secondary bladder amyloidosis case that presented with gross hematuria without any risk factor except COVID-19 infection.

Indexed as

AmyloidosisBladderCase reportCOVID-19Hematuria

Identifiers

PMID33850728
PMCPMC8024597
OpenAlexW3138260028

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.